(Q38090560)

28 August 2017

title

The role of natural killer T cells in B cell malignancies (English)

1 reference

28 August 2017

author

Farhad Jadidi-Niaragh

series ordinal

4

1 reference

28 August 2017

Ghasem Ghalamfarsa

1

1 reference

28 August 2017

Abolghasem Hadinia

series ordinal

2

1 reference

28 August 2017

Mehdi Yousefi

series ordinal

3

1 reference

28 August 2017

publication date

19 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

34

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

1349-1360

1 reference

Natural innate and adaptive immunity to cancer

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Clinical applications of natural killer T cell-based immunotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

New aspects of natural-killer-cell surveillance and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Phenotypic properties, interleukin 2 production, and developmental origin of a "mature" subpopulation of Lyt-2- L3T4- mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NKT cells: facts, functions and fallacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Raising the NKT cell family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Toward an understanding of NKT cell biology: progress and paradoxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d-restricted T cell activation by nonlipidic small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Gammadelta T cells: functional plasticity and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

A subset of natural killer cells in peripheral blood displays a mature T cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Molecular biology of NK T cell specificity and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Control points in NKT-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

The transcription factor PLZF directs the effector program of the NKT cell lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Differential antitumor immunity mediated by NKT cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

MTP regulated by an alternate promoter is essential for NKT cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1 antigen presentation: how it works

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Targeting natural killer cells and natural killer T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

The role of NKT cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD4+CD25+ Tregs and NKT cells: regulators regulating regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1: antigen presentation and T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Differential tumor surveillance by natural killer (NK) and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Enhancement of ligand-dependent activation of human natural killer T cells by lenalidomide: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0743-X

Tumour-loaded α-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia produce a superior NK-, NKT- and CD8+ T cell-attracting chemokine profile

21 January 2018

1 reference

12 December 2020

TRAIL expression by activated human CD4(+)V alpha 24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells

1 reference

12 December 2020

Regulation of NKT cell development by SAP, the protein defective in XLP

1 reference

12 December 2020

Tissue-specific segregation of TCRgamma delta+ NKT cells according to phenotype TCR repertoire and activation status: parallels with TCR alphabeta+NKT cells

1 reference

12 December 2020

Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load

1 reference

12 December 2020

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

1 reference

12 December 2020

Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2

1 reference

12 December 2020

Expansion of CD3+CD56+ cytotoxic cells from patients with chronic lymphocytic leukemia: in vitro efficacy

1 reference

12 December 2020

Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia

1 reference

12 December 2020

CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis.

1 reference

12 December 2020

Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus

1 reference

12 December 2020

Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.

1 reference

12 December 2020

Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy

1 reference

12 December 2020

Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.

1 reference

12 December 2020

A novel population of T-cell receptor alpha beta-bearing thymocytes which predominantly expresses a single V beta gene family

1 reference

12 December 2020

Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells

1 reference

12 December 2020

KRN7000, a novel immunomodulator, and its antitumor activities

1 reference

12 December 2020

Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice

1 reference

12 December 2020

Human CD4+ CD25+ regulatory T cells suppress NKT cell functions

1 reference

12 December 2020

Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide

1 reference

12 December 2020

Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia

1 reference

12 December 2020

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

12 December 2020

The peripheral blood Valpha24+ NKT cell numbers decrease in patients with haematopoietic malignancy

1 reference

12 December 2020

The unconventional lifestyle of NKT cells

1 reference

12 December 2020

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors

1 reference

12 December 2020

Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice.

1 reference

12 December 2020

NKT cells are phenotypically and functionally diverse

1 reference

12 December 2020

The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns

1 reference

12 December 2020

Natural killer cells and CD56+ T cells in the blood of multiple myeloma patients: analysis by 4-colour flow cytometry

1 reference

12 December 2020

Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations

1 reference

12 December 2020

Immunostimulatory and antitumor activities of monoglycosylceramides having various sugar moieties

1 reference

12 December 2020

CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma

1 reference

12 December 2020

Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression

1 reference

12 December 2020

Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells

1 reference

12 December 2020

10.1007/S13277-013-0743-X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1026748510

0 references

1 reference